William Blair Investment Management, LLC Bei Gene, Ltd. Transaction History

William Blair Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$115.78 - $208.34 $9.14 Million - $16.5 Million	-78,966 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$120.61 - $148.29 $9.52 Million - $11.7 Million	78,966 New	78,966 $9.67 Million
Q4 2018 Feb 13, 2019	SELL	$107.01 - $175.15 $8.29 Million - $13.6 Million	-77,463 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$152.62 - $189.66 $1.41 Million - $1.75 Million	9,240 Added 13.54%	77,463 $13.3 Million
Q2 2018 Aug 14, 2018	BUY	$152.5 - $216.77 $10.4 Million - $14.8 Million	68,223 New	68,223 $10.5 Million

253

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $22.7B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of William Blair Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on William Blair Investment Management, LLC with notifications on news.